BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26274756)

  • 1. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.
    Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R
    Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone versus soft-tissue sarcomas in the elderly.
    Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
    Malik AT; Alexander J; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis.
    Smith GM; Johnson GD; Grimer RJ; Wilson S
    Ann R Coll Surg Engl; 2011 Oct; 93(7):542-7. PubMed ID: 22004638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
    Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
    Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified staging system for extremity soft tissue sarcomas.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
    Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
    Medicine (Baltimore); 2015 Dec; 94(51):e2319. PubMed ID: 26705220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
    Tawbi HA; Burgess M; Bolejack V; Van Tine BA; Schuetze SM; Hu J; D'Angelo S; Attia S; Riedel RF; Priebat DA; Movva S; Davis LE; Okuno SH; Reed DR; Crowley J; Butterfield LH; Salazar R; Rodriguez-Canales J; Lazar AJ; Wistuba II; Baker LH; Maki RG; Reinke D; Patel S
    Lancet Oncol; 2017 Nov; 18(11):1493-1501. PubMed ID: 28988646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying prognostic indicators in staging metastatic sarcomas using hospital episode statistics.
    Francis M; Dennis N; Charman J; Lawrence G
    Cancer Invest; 2015 Jul; 33(6):205-12. PubMed ID: 25919082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
    Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
    Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
    JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.
    Lawrenz JM; Styron JF; Parry M; Grimer RJ; Mesko NW
    Bone Joint J; 2018 May; 100-B(5):652-661. PubMed ID: 29701086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the Incidence of Suicide in Patients with Bone and Soft Tissue Cancer? : Suicide and Sarcoma.
    Siracuse BL; Gorgy G; Ruskin J; Beebe KS
    Clin Orthop Relat Res; 2017 May; 475(5):1439-1445. PubMed ID: 27896676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
    Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
    Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing bone and soft tissue infections mimicking sarcomas requires multimodal multidisciplinary team assessment.
    Lex JR; Gregory J; Allen C; Reid JP; Stevenson JD
    Ann R Coll Surg Engl; 2019 Jul; 101(6):405-410. PubMed ID: 31155889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastasis in patients with sarcoma: an analysis of histological subtypes, clinical characteristics, and outcomes.
    Yoshida S; Morii K; Watanabe M; Saito T
    Surg Neurol; 2000 Aug; 54(2):160-4. PubMed ID: 11077098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-radiation sarcomas. Clinical outcome of 52 Patients.
    Mavrogenis AF; Pala E; Guerra G; Ruggieri P
    J Surg Oncol; 2012 May; 105(6):570-6. PubMed ID: 22012601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
    Basile G; Mattei JC; Alshaygy I; Griffin AM; Catton CN; Chung PW; Shultz DB; Razak ARA; Demicco EG; Ferguson PC; Wunder JS
    Cancer; 2020 Dec; 126(23):5098-5108. PubMed ID: 32910462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.